EAGLE, Idaho, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that on October 1, 2025, it acquired certain operations from UnitedHealth Group Incorporated (“UnitedHealth”). The operations were divested pursuant to UnitedHealth’s acquisition of Amedisys Inc. by UnitedHealth’s Optum unit. Pennant is purchasing divested home health, hospice and personal c ...

EAGLE, Idaho, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that on October 1, 2025, it acquired certain operations from UnitedHealth Group Incorporated (“UnitedHealth”). The operations were divested pursuant to UnitedHealth’s and Amedisys Inc.’s (“Amedisys”) antitrust settlement with the United States Justice Department. Pennant is purchasing diveste ...

The Pennant Group (NasdaqGS:PNTG) 2025 Conference September 29, 2025 02:15 PM ET Company ParticipantsBrent Guerisoli - CEO & ChairmanJohn Gochnour - President & COOKirk Cheney - EVP, General Counsel & Corporate SecretaryConference Call ParticipantsBrian Tanquilut - Senior Analyst - Healthcare Services & HCIT/Digital Health Equity ResearchNone - AnalystBrian TanquilutAll right, so good afternoon, everyone. I'm Brian Timothy, Healthcare Services Analyst here at Jefferies. Welcome again to the 2025 Jefferies H ...

The Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare treatment. In the past few years, there has been a significant rise in demand for telemedicine-focused online medical and artificial intelligence (AI)-powered technology services. The rising elderly global population is necessitating many healthcare companies that were traditionally not technology-based to provide technology-enabled services to survive in the market. Per a report by Grand ...

EAGLE, Idaho, Sept. 11, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2025 Jefferies Healthcare Services Conference on September 29, 2025. Brent Guerisoli, Chief Executive Officer, John Gochnour, Chief Operating Officer, and Kirk Cheney, Executive Vice President, will participate in a fireside chat on September 29, 2025 at 1:15 p. ...

EAGLE, Idaho, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that effective September 1, 2025, it has acquired a premier home health agency and outpatient therapy operation in Wyoming. Both businesses, which will continue operating as Healing Hearts Home Health and Healing Hearts Outpatient Therapy, will serve communities in Gillette and Moorcroft, ex ...

Shares of The Pennant Group, Inc. (PNTG) have gained 8.8% over the past four weeks to close the last trading session at $24.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $33.6 indicates a potential upside of 39.9%.The mean estimate comprises five short-term price targets with a standard deviation of $5.13. While the lowest estimate of $28.00 indicates a 16.6% increase from ...

股价表现与技术形态 - 亚马逊股价周二收于略低于230美元 自8月第一周以来累计上涨8%[1] - 自4月以来更广泛的上涨趋势保持完整 期间涨幅超过40%[1] - 形成三角旗形技术形态 表现为7月底以来更低的高点和8月初以来更高的低点[3] - 该形态显示买卖双方暂时缺乏绝对控制权 通常预示强劲突破行情[2][3] 基本面与分析师观点 - 华尔街分析师给予买入评级 平均12个月目标价262.87美元 较当前229.12美元存在14.73%上行空间[5] - 最高目标价达到305美元 最低目标价为195美元[5] - 公司在云计算、零售和广告领域全面发力 提供多个增长引擎[6] - 今年财报持续超预期 基本面保持强劲[6] 突破策略与关键价位 - 突破信号需伴随放量长阳线突破旗形上轨并维持至收盘[9] - 初始上行目标位为7月底高点235美元 后续目标为2月高点240美元[11] - 若突破240美元 可能打开通往300美元中目标的上涨空间[11] - 下方支撑位于220美元 跌破该位置需重新评估走势[10] 投资策略建议 - 长期看多投资者可在整理阶段建立初始头寸[8] - 突破发生后可追加头寸以增加风险暴露[8] - 当前230美元价格隐含约30%目标上行空间[7] - 整体市场风险偏好情绪下 向下突破可能性较低[10]

核心观点 - 成长型股票因财务增长高于平均水平而吸引投资者 但通常伴随较高风险和波动性 [1] - 公司凭借Zacks增长风格评分和Zacks排名成为优质成长股选择 [2][11] - 公司当前具有优异收益增长 现金流增长和盈利预测上调三大关键优势 [3][10] 收益增长表现 - 收益增长是投资者关注的核心指标 双位数增长通常预示强劲前景 [4] - 公司历史每股收益增长率为11.2% 但今年预期增长20.7% [5] - 公司预期收益增长率超越行业平均的17.7% [5] 现金流增长表现 - 现金流增长对成长型公司尤为重要 支持新项目开展而无需外部融资 [6] - 公司当前现金流同比增长35.2% 远高于同业平均的2.3% [6] - 公司过去3-5年化现金流增长率达10.6% 显著高于行业4.4%的平均水平 [7] 盈利预测调整 - 盈利预测上调趋势与短期股价走势存在强相关性 [8] - 公司本年度盈利预测在过去一个月获上调 Zacks共识预期上升3.3% [9] - 盈利预测调整使公司获得Zacks第2级排名（买入） [10] 综合评级表现 - 公司同时具备A级增长评分和Zacks第2级排名 [2][10] - 该组合表明公司对成长型投资者而言是潜在优异表现标的 [11]

股价表现与目标价分析 - The Pennant Group(PNTG)最新收盘价为24 7美元 过去四周上涨3 3% 华尔街分析师给出的平均目标价为32 4美元 隐含31 2%上行空间 [1] - 五个短期目标价的标准差为3 85美元 最低目标价28美元(隐含13 4%涨幅) 最高目标价37美元(隐含49 8%涨幅) 标准差反映分析师预测分歧程度 [2] - 分析师对盈利预期的上调形成强烈共识 过去30天内有两项年度EPS预测被上调 共识预期提升3 3% [12] 目标价的有效性争议 - 学术研究表明 分析师目标价作为投资决策单一依据的可靠性存疑 实际预测准确率较低 [7] - 华尔街分析师可能因商业利益设置过高目标价 以吸引投资者关注其关联公司 [8] - 低标准差显示分析师对股价变动方向与幅度高度一致 可作为基本面研究的起点 [9] 盈利预期与评级支撑 - 盈利预测修正趋势与股价短期走势存在强相关性 PNTG获分析师集中上调EPS预期 [11] - 公司当前Zacks评级为2(买入) 位列4000多只股票前20% 基于四项盈利相关因子的评估 [13] - 外部审计跟踪记录优异 强化短期上涨潜力的可信度 [13] 投资决策建议 - 目标价隐含的方向性指引具有一定参考价值 但需结合其他指标综合判断 [14] - 盈利预测修正趋势比目标价更能有效预示股价上行潜力 [4][11]